POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study

POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study

Bibliographic Details
Main Authors: W. Hu, C. Duqun, C. Yinghua, G. Erzhi, L. Lixuan, X. Wang, L. Zhengzhao, L. Zhihong
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024921004861
id doaj-cab9f6de9ee4447f8dc5c520d8a623d8
record_format Article
spelling doaj-cab9f6de9ee4447f8dc5c520d8a623d82021-04-18T06:29:58ZengElsevierKidney International Reports2468-02492021-04-0164S140POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational studyW. Hu0C. Duqun1C. Yinghua2G. Erzhi3L. Lixuan4X. Wang5L. Zhengzhao6L. Zhihong7Nanjing Jinling Hospital- Nanjing University School of Medicine, National Clinical Research Center for Kidney Diseases, Nanjing, ChinaNanjing Jinling Hospital- Nanjing University School of Medicine, National Clinical Research Center for Kidney Diseases, Nanjing, ChinaNanjing Jinling Hospital- Nanjing University School of Medicine, National Clinical Research Center for Kidney Diseases, Nanjing, ChinaNanjing Jinling Hospital- Nanjing University School of Medicine, National Clinical Research Center for Kidney Diseases, Nanjing, ChinaNanjing Jinling Hospital- Nanjing University School of Medicine, National Clinical Research Center for Kidney Diseases, Nanjing, ChinaNanjing Jinling Hospital- Nanjing University School of Medicine, National Clinical Research Center for Kidney Diseases, Nanjing, ChinaNanjing Jinling Hospital- Nanjing University School of Medicine, National Clinical Research Center for Kidney Diseases, Nanjing, ChinaNanjing Jinling Hospital- Nanjing University School of Medicine, National Clinical Research Center for Kidney Diseases, Nanjing, Chinahttp://www.sciencedirect.com/science/article/pii/S2468024921004861
collection DOAJ
language English
format Article
sources DOAJ
author W. Hu
C. Duqun
C. Yinghua
G. Erzhi
L. Lixuan
X. Wang
L. Zhengzhao
L. Zhihong
spellingShingle W. Hu
C. Duqun
C. Yinghua
G. Erzhi
L. Lixuan
X. Wang
L. Zhengzhao
L. Zhihong
POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study
Kidney International Reports
author_facet W. Hu
C. Duqun
C. Yinghua
G. Erzhi
L. Lixuan
X. Wang
L. Zhengzhao
L. Zhihong
author_sort W. Hu
title POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study
title_short POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study
title_full POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study
title_fullStr POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study
title_full_unstemmed POS-324 Ultra-low dose Rituximab regimen for the treatment of lupus nephritis: A preliminary observational study
title_sort pos-324 ultra-low dose rituximab regimen for the treatment of lupus nephritis: a preliminary observational study
publisher Elsevier
series Kidney International Reports
issn 2468-0249
publishDate 2021-04-01
url http://www.sciencedirect.com/science/article/pii/S2468024921004861
work_keys_str_mv AT whu pos324ultralowdoserituximabregimenforthetreatmentoflupusnephritisapreliminaryobservationalstudy
AT cduqun pos324ultralowdoserituximabregimenforthetreatmentoflupusnephritisapreliminaryobservationalstudy
AT cyinghua pos324ultralowdoserituximabregimenforthetreatmentoflupusnephritisapreliminaryobservationalstudy
AT gerzhi pos324ultralowdoserituximabregimenforthetreatmentoflupusnephritisapreliminaryobservationalstudy
AT llixuan pos324ultralowdoserituximabregimenforthetreatmentoflupusnephritisapreliminaryobservationalstudy
AT xwang pos324ultralowdoserituximabregimenforthetreatmentoflupusnephritisapreliminaryobservationalstudy
AT lzhengzhao pos324ultralowdoserituximabregimenforthetreatmentoflupusnephritisapreliminaryobservationalstudy
AT lzhihong pos324ultralowdoserituximabregimenforthetreatmentoflupusnephritisapreliminaryobservationalstudy
_version_ 1721523333547163648

Similar Items